Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.
MorphoCOPD1b
Morpho-COPD1b : Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.
2 other identifiers
observational
50
2 countries
2
Brief Summary
The prevalence of chronic obstructive pulmonary disease (COPD) is between 8 and 12% of the adult population. This prevalence is expected to increase over the coming decades due to the aging of the population and the continued exposure to risk factors for the disease. The evolution of COPD is marked by the occurrence of exacerbations of varying severity and patients are frequently admitted to the emergency department for evaluation, treatment and / or hospitalization. Admission in emergency department for COPD exacerbation represents approximately 1% of emergency admission. Chronic pain is common in patients with Chronic Obstructive Pulmonary Disease (COPD). The pain intensity may increase during acute episodes of exacerbations. This study is aimed to compare pain intensity during exacerbation and stable phase of patients with chronic obstructive pulmonary disease (COPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2015
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 31, 2017
CompletedFirst Posted
Study publicly available on registry
April 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2018
CompletedJune 6, 2018
February 1, 2018
2.3 years
March 31, 2017
June 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of the short-form McGill Pain Questionnaire (SF-MPQ) between the exacerbation and the stable phase at 30 days
McGill Pain Questionnaire (SF-MPQ)
30 days after exacerbation
Eligibility Criteria
Patients admitted to emergency department for acute episodes of exacerbation of chronic obstructive pulmonary disease
You may qualify if:
- ≥ 40 years
- smoking at least ≥ 10 pack years
- previous FEV / FVC \<0.70 post bronchodilator
- admitted for exacerbations (GOLD definition)
You may not qualify if:
- A dementia or non-communicating patient
- Patient with no social security insurance , with restricted liberty or under legal protection
- Pregnant woman parturient or nursing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Emergency department of Hôpital du Sacré Coeur de Montréal
Montreal, Canada
Emergency Department of university hospital
Grenoble, 38043, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maxime MAIGNAN
University Hospital, Grenoble
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2017
First Posted
April 6, 2017
Study Start
December 1, 2015
Primary Completion
April 5, 2018
Study Completion
April 5, 2018
Last Updated
June 6, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share